Loading clinical trials...
Loading clinical trials...
A Randomised, Placebo Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the Gut Hormone Analogue G3215 in Adult Subjects
Conditions
Interventions
G3215
Placebo
Locations
1
United Kingdom
Covance Clinical Research Unit
Leeds, United Kingdom
Start Date
January 1, 2015
Primary Completion Date
January 1, 2019
Completion Date
January 1, 2019
Last Updated
December 23, 2020
NCT01143454
NCT07051005
NCT07472881
NCT00001987
NCT07010757
NCT07480161
Lead Sponsor
Imperial College London
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions